Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
4.610
+0.260 (5.98%)
At close: Sep 4, 2026, 4:00 PM EDT
4.690
+0.080 (1.74%)
After-hours: Sep 4, 2026, 7:58 PM EDT
Galectin Therapeutics Employees
Galectin Therapeutics had 9 employees as of December 31, 2025. The number of employees decreased by 6 or -40.00% compared to the previous year.
Employees
9
Change (1Y)
-6
Growth (1Y)
-40.00%
Revenue / Employee
n/a
Profits / Employee
-$3,114,111
Market Cap
464.92M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 9 | -6 | -40.00% |
| Dec 31, 2024 | 15 | 1 | 7.14% |
| Dec 31, 2023 | 14 | 2 | 16.67% |
| Dec 31, 2022 | 12 | 3 | 33.33% |
| Dec 31, 2021 | 9 | 3 | 50.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Rocket Pharmaceuticals | 202 |
| Ocugen | 116 |
| Arcturus Therapeutics Holdings | 111 |
| C4 Therapeutics | 104 |
| Compass Therapeutics | 39 |
| Fennec Pharmaceuticals | 35 |
| Inhibikase Therapeutics | 35 |
| vTv Therapeutics | 26 |
GALT News
- 8 days ago - 20 stocks likely to lose money even if the bull market continues - Market Watch
- 22 days ago - Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 22 days ago - Galectin Therapeutics Quarterly report: Q2 2026 - Filings
- 22 days ago - Galectin Therapeutics Earnings release: Q2 2026 - Filings
- 4 weeks ago - Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet - GlobeNewsWire
- 2 months ago - Galectin Therapeutics reaches alignment with FDA on belapectin pathway - TheFly
- 2 months ago - Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension - GlobeNewsWire
- 3 months ago - Galectin Therapeutics presents belapectin data at EASL 2026 - TheFly